Hong Kong’s Drug Office is responsible for the market surveillance of medicines, risk assessments, and complaints of drugs. Additionally, the office inspects the drugs, licenses manufacturers and retailers, and conducts research and development to improve drug standards. The site is designed to provide specific information for consumers, healthcare providers, and those interested in pharmaceutical trade, and the homepage offers sections specific to these audiences.